The store will not work correctly when cookies are disabled.
2-(5-Ethyl-1H-[1,2,4]triazol-3-yl)-3-(5-nitro-furan-2-yl)-acrylonitrile
ID: ALA113815
PubChem CID: 11324247
Max Phase: Preclinical
Molecular Formula: C15H9N5O3
Molecular Weight: 307.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1ccc([N+](=O)[O-])o1)c1n[nH]c(-c2ccccc2)n1
Standard InChI: InChI=1S/C15H9N5O3/c16-9-11(8-12-6-7-13(23-12)20(21)22)15-17-14(18-19-15)10-4-2-1-3-5-10/h1-8H,(H,17,18,19)/b11-8+
Standard InChI Key: ASFXIWZYLRAKAV-DHZHZOJOSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
4.1917 -4.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0292 -4.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7417 -4.5375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4292 -3.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -3.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -2.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3042 -3.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2750 -4.4375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -3.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9542 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7792 -2.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1292 -1.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1500 -3.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7292 -5.3625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4667 -4.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -4.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -4.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9292 -5.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 -5.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3625 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 9 1 0
4 3 1 0
5 2 1 0
6 1 2 0
7 2 2 0
8 6 1 0
9 11 1 0
10 5 2 0
11 10 1 0
12 15 1 0
13 5 1 0
14 13 3 0
15 11 2 0
16 4 1 0
17 4 2 0
18 6 1 0
19 18 2 0
20 18 1 0
21 20 2 0
22 19 1 0
23 21 1 0
8 7 1 0
22 23 2 0
3 12 2 0
M CHG 2 4 1 16 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.27 | Molecular Weight (Monoisotopic): 307.0705 | AlogP: 3.04 | #Rotatable Bonds: 4 |
Polar Surface Area: 121.64 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.18 | CX Basic pKa: 0.13 | CX LogP: 3.75 | CX LogD: 3.74 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -1.79 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |